What is kanna (Sceletium tortuosum)?
About this site: kanna.clinic is an educational botanical, ethnobotanical, pharmacological, and regulatory reference for Sceletium tortuosum, operated by AdvancedCare USA Inc. It is not a clinic, does not diagnose or treat any condition, does not refer patients, does not sell kanna or any other substance, and is not affiliated with any supplier or brand. Content is educational only — not medical advice.
Legal snapshot (U.S.): As of 2026-07-21, Sceletium tortuosum is not listed as a controlled substance under the U.S. Controlled Substances Act (see the DEA drug scheduling resource). In the U.S. market it is typically sold as a dietary ingredient / dietary supplement. It is not FDA-evaluated for safety or efficacy for any disease, and disease claims are prohibited under dietary-supplement labeling rules (FDA DSHEA framework; fda.gov dietary supplements, reviewed 2026-07-21). Laws outside the U.S. differ — see regulatory status.
If you are in crisis or thinking about harming yourself, contact 988 (call/text), text HOME to 741741, or 911 for emergencies. This site does not provide crisis counseling.
Botany and habitat
Sceletium tortuosum is a low-growing, drought-adapted succulent in the ice-plant family (Aizoaceae / Mesembryanthemaceae complex, depending on taxonomic treatment). Its natural range centers on the arid and semi-arid regions of South Africa — especially the Karoo and Namaqualand — where seasonal rainfall and sandy or rocky soils shape growth. Ethnobotanical and botanical literature has long placed traditional use in those landscapes rather than as a rainforest or tropical crop (see Smith et al., 1996, and subsequent reviews of Sceletium ethnobotany; literature reviewed 2026-07-21).
The plant’s aerial parts — leaves and stems — are the material historically prepared for use. Different Sceletium species exist; commercial identity matters because alkaloid profiles are not interchangeable. Adulteration and misidentification risks are discussed under standardization.
Names and etymology
- Kanna — common English trade and wellness name.
- Kougoed — Afrikaans, often glossed as “something to chew” or “chewable things,” reflecting oral traditional preparation rather than a modern capsule format.
- Sceletium tortuosum — the binomial used in scientific and most regulatory writing.
Colonial-era European observers recorded indigenous use from the mid-17th century onward; later ethnobotanists (including work associated with Watt and with modern researchers such as Nigel Gericke) documented preparation methods and social context. Those records describe a calming, sociable traditional role — not a visionary or strongly hallucinogenic one. Traditional knowledge belongs first to San and Khoi communities; commercial use raises access-and-benefit-sharing (ABS) questions introduced below and expanded on the ethical sourcing page.
Traditional Khoisan use (high-level)
Published ethnobotanical accounts describe bruising aerial parts, allowing a fermentation / curing period, then drying the material for chewing, snuffing, or other traditional routes. Fermentation is not only cultural practice: it is associated in the literature with shifts in alkaloid proportions compared with raw plant material (see alkaloids and pharmacology).
This reference does not give preparation recipes, doses, or administration instructions. Traditional context is summarized only to ground names and history. Modern products (powders, extracts, capsules) are commercial formulations with variable quality — not “the same thing” as every traditional batch.
What kanna is not
| Not this | Why the distinction matters |
|---|---|
| Not kratom | Kratom (Mitragyna speciosa) is a Southeast Asian tree whose principal alkaloids act at opioid receptors. Kanna is a South African succulent whose studied alkaloids act on monoamine reuptake and PDE4 pathways in vitro. Pooling them as generic “botanicals” obscures very different pharmacology and safety profiles. |
| Not a classic psychedelic | Traditional and modern published accounts generally describe mild mood/sociability effects, not LSD- or DMT-like visionary states. Individual reports vary; “mild” is not a safety guarantee. |
| Not an FDA-approved medicine | No approved indication for depression, anxiety, or any disease. Marketing disease claims for a dietary supplement violates U.S. labeling rules (FDA materials, 2026-07-21). |
| Not a clinic product we sell | This site sells nothing and does not stock, ship, or broker plant material. |
| Not a substitute for care | Mood distress, suicidal thinking, and medication questions belong with licensed clinicians and crisis services — not a website. |
How this reference is scoped
Pages on kanna.clinic focus on:
- Botany and ethnobotany (this page).
- Alkaloid chemistry and in vitro / preclinical mechanisms — mechanism, not proven clinical benefit (pharmacology).
- Standardized extracts and label literacy, including factual notes on the studied extract Zembrin® without endorsement (standardization).
- Multi-jurisdiction regulatory status with “as of” dates (regulatory).
- Interaction cautions framed as questions for a prescriber, not protocols (safety).
- Indigenous provenance and ABS (ethical sourcing).
We do not recommend products, doses, or “stacks,” do not publish “find a provider” directories, and do not imply supply or availability.
Indigenous origin and ABS (early note)
Sceletium tortuosum is part of South Africa’s biodiversity and of San and Khoi traditional knowledge systems. South Africa implements access-and-benefit-sharing frameworks under the Convention on Biological Diversity / Nagoya Protocol and national biodiversity law. Wild-harvested material without documentation, and commercial brands that cannot explain benefit-sharing, are ethical and often legal red flags. Details: ethical sourcing and regulatory status.
Primary literature starting points
For readers who want primary sources rather than wellness blogs:
- Alkaloid-profile and chemistry literature on mesembrine-type alkaloids (e.g. Smith et al., 1996, and later analytical papers).
- In vitro pharmacology of a standardized extract (Harvey et al., 2011).
- Small human cognition/mood RCTs of a defined extract (Chiu et al., 2014, and related Zembrin literature).
- Ethnobotanical reviews summarizing traditional use and modern research (Gericke and colleagues’ review literature).
PubMed search starting point: Sceletium tortuosum (external).
Disclaimer (read this)
This page is educational only. It is not medical advice, not a clinical guideline, and not a product label. Kanna is not FDA-approved to diagnose, treat, cure, or prevent any disease. Do not stop, start, or combine medications based on this site. If you take serotonergic prescriptions (SSRIs, SNRIs, MAOIs, certain migraine medicines, tramadol, and others), read safety and interactions and discuss with your own clinician before any personal use decision. kanna.clinic does not sell substances, does not refer patients, and is not a clinic.
Sources checked / as-of: DEA scheduling pages and FDA dietary-supplement materials (2026-07-21); peer-reviewed ethnobotany and pharmacology literature cited by year in body (Smith 1996; Harvey 2011; Chiu 2014; Gericke ethnobotanical reviews).